Showing 241 - 260 results of 452 for search '"human immunodeficiency virus"', query time: 0.07s Refine Results
  1. 241

    A case of acute brucellosis associated with HIV infection in Turkey by Fatma Yekta Urkmez, Sevil Alkan

    Published 2024-11-01
    “…Human brucellosis is a common public health problem in Turkey. Human immunodeficiency virus (HIV)-positive patients are vulnerable to co-infections and super-infections due to targeting the immune system. …”
    Get full text
    Article
  2. 242

    Study protocol for a multi-center stepped-wedge cluster randomized trial to explore the usability and outcomes among young people living with HIV in Kiambu and Kirinyaga counties o... by Eric Nturibi, Jared Mecha, Elizabeth Kubo, Albert Orwa, Florence Kaara, Faith Musau, Christine Wamuyu, Justus Kilonzi, Randeep Gill, Sanne Roels

    Published 2025-01-01
    “…While the incidence of Human Immunodeficiency Virus (HIV) infection is decreasing in most age groups worldwide, it is rising among adolescents and young adults, who also face a higher rate of HIV-related deaths. …”
    Get full text
    Article
  3. 243

    Pneumocystis Jirovecii Pneumonia in Two Immunosuppressed Non-HIV Infected Patients: A Clinical and Therapeutic Analysis by Li W, Hua M, Guo J, Jia W

    Published 2025-01-01
    “…Weiran Li, Mao Hua, Jin Guo, Wenbo Jia Department of Clinical Medicine, School of Medicine, Qinghai University, Xining, People’s Republic of ChinaCorrespondence: Mao Hua, Qinghai University Affiliated Hospital, No. 29 Tongren Road, Chengxi District, Xining, Qinghai Province, 810006, People’s Republic of China, Tel +86 0971-6162000, Email qhdxxxgk@126.comAbstract: Pneumocystis jirovecii pneumonia (PJP) is an opportunistic fungal infection that often occurs secondary to human immunodeficiency virus (HIV) infection. However, for non-HIV immunocompromised patients, such as those undergoing novel immunosuppressive treatments to manage malignancies, organ transplants, or connective tissue diseases, PJP is emerging as an increasing threat. …”
    Get full text
    Article
  4. 244

    Interferon-gamma: A Potent Antiviral Agent Targeting Macrophages Infected with LP-BM5 Murine Leukemia Virus, the Causative Agent of 'AIDS' in Mice by Jens J Kort, Julie L Eiseman

    Published 1992-01-01
    “…Cells of the monocyte/macrophage lineage (MM cells) are known to be infected by retroviruses, including the human immunodeficiency virus (HIV), without cytopathic changes and may serve as a persistent reservoir for the virus during the development of immunodeficiency disease. …”
    Get full text
    Article
  5. 245

    Retrovirus Entry by Endocytosis and Cathepsin Proteases by Yoshinao Kubo, Hideki Hayashi, Toshifumi Matsuyama, Hironori Sato, Naoki Yamamoto

    Published 2012-01-01
    “…CD4-dependent human immunodeficiency virus (HIV) infection is thought to occur via endosomes, but endosome acidification is not necessary for the entry whereas entry of CD4-independent HIVs, which are thought to be prototypes of CD4-dependent viruses, is low pH dependent. …”
    Get full text
    Article
  6. 246

    Ill, Itinerant, and Insured: The Top 20 Users of Emergency Departments in Baltimore City by Barbara Y. DiPietro, Dana Kindermann, Stephen M. Schenkel

    Published 2012-01-01
    “…The five most frequent diagnoses were limb pain (n=9), lack of housing (n=6), alteration of consciousness (n=6), infection with human immunodeficiency virus (HIV) (n=5), and nausea/vomiting (n=5). …”
    Get full text
    Article
  7. 247

    Cellular Immunogenicity of Novel Gene Immunogens in Mice Monitored by in Vivo Imaging by Elizaveta Starodubova, Olga Krotova, David Hallengärd, Yulia Kuzmenko, Gunnel Engström, Diana Legzdina, Oleg Latyshev, Olesja Eliseeva, Anna Karin Maltais, Vera Tunitskaya, Vadim Karpov, Andreas Bråve, Maria Isaguliants

    Published 2012-11-01
    “…To test this, we designed genes encoding human immunodeficiency virus 1 (HIV-1) reverse transcriptase (RT) fused via its N- or C-terminus to 30–amino acid-long Gly-Ala-repeat of Epstein-Barr virus nuclear antigen 1 or via the N-terminus to the transport signal of invariant chain/Ii or inserted between the cytoplasmic and luminal domains of lysosome-associated membrane protein I (LAMP). …”
    Get full text
    Article
  8. 248

    Family Practitioners and Sexually Transmitted Diseases by Marc Steben

    Published 1991-01-01
    “…Secondary prevention refers to the recognition and elimination (if possible) of an STD after exposure and includes early disease detection, adequate STD treatments, screening, human immunodeficiency virus testing with pre- and post test counselling, epidemiological treatment of patient contacts, and hepatitis B prophylaxis by passive or active immunization. …”
    Get full text
    Article
  9. 249

    On the Optimal Control of HIV-TB Co-Infection and Improvement of Workplace Productivity by Baba Seidu, Oluwole Daniel Makinde, Ibrahim Yakubu Seini

    Published 2023-01-01
    “…Human immunodeficiency virus (HIV) and tuberculosis (TB) have long been known to have a synergistic relationship. …”
    Get full text
    Article
  10. 250

    Characterization of the Protective HIV-1 CTL Epitopes and the Corresponding HLA Class I Alleles: A Step towards Designing CTL Based HIV-1 Vaccine by Sajib Chakraborty, Taibur Rahman, Rajib Chakravorty

    Published 2014-01-01
    “…Human immunodeficiency virus (HIV) possesses a major threat to the human life largely due to the unavailability of an efficacious vaccine and poor access to the antiretroviral drugs against this deadly virus. …”
    Get full text
    Article
  11. 251

    Pulmonary Toxoplasmosis Diagnosed on Transbronchial Lung Biopsy in a Mechanically Ventilated Patient by Delyse Garg, Nikhil Madan, Omar Qaqish, Sandhya Nagarakanti, Vipul Patel

    Published 2020-01-01
    “…In persons living with human immunodeficiency virus (HIV), toxoplasmosis occurs when CD4 counts are very low and is considered an acquired immunodeficiency syndrome (AIDS) defining illness. …”
    Get full text
    Article
  12. 252

    Antiretroviral Treatment Adherence: Knowledge and Experiences among Adolescents and Young Adults in Soweto, South Africa by Stefanie Hornschuh, Janan Janine Dietrich, Celokuhle Tshabalala, Fatima Laher

    Published 2017-01-01
    “…Human immunodeficiency virus (HIV) management of adolescents and young adults (AYAs) is particularly pertinent to sub-Saharan Africa, where the pediatric HIV burden is marked. …”
    Get full text
    Article
  13. 253

    Application and development of biosensors in the detection of transfusion transmitted diseases markers:a review by CHEN Siyi, LIAO Deyu, ZHAO Lin, GAO Feiran, TAN Bin

    Published 2024-12-01
    “…However, there is a risk of transmitting diseases during blood transfusion, such as human immunodeficiency virus (HIV), hepatitis B virus (HBV), hepatitis C virus (HCV), etc. …”
    Get full text
    Article
  14. 254

    Plasmablastic Lymphoma: A Review of Current Knowledge and Future Directions by Ghaleb Elyamany, Eman Al Mussaed, Ali Matar Alzahrani

    Published 2015-01-01
    “…Plasmablastic lymphoma (PBL) is an aggressive subtype of non-Hodgkin’s lymphoma (NHL), which frequently arises in the oral cavity of human immunodeficiency virus (HIV) infected patients. PBL shows diffuse proliferation of large neoplastic cells resembling B-immunoblasts/plasmablasts, or with plasmacytic features and an immunophenotype of plasma cells. …”
    Get full text
    Article
  15. 255

    Pharmacokinetic, Pharmacogenetic, and Other Factors Influencing CNS Penetration of Antiretrovirals by Jacinta Nwamaka Nwogu, Qing Ma, Chinedum Peace Babalola, Waheed Adeola Adedeji, Gene D. Morse, Babafemi Taiwo

    Published 2016-01-01
    “…Neurological complications associated with the human immunodeficiency virus (HIV) are a matter of great concern. …”
    Get full text
    Article
  16. 256

    Survival Analysis of Risk Factors for Mortality in a Cohort of Patients with Tuberculosis by Yi Xie, Jing Han, Weili Yu, Junping Wu, Xue Li, Huaiyong Chen

    Published 2020-01-01
    “…Cox regression analysis showed that advanced age, male sex, human immunodeficiency virus (HIV) positivity, first sputum positivity, retreated tuberculosis, and a delayed visit (≥14 days) were risk factors for mortality in patients with pulmonary tuberculosis receiving antituberculosis treatment under DOTS. …”
    Get full text
    Article
  17. 257

    Long-Term Consequences of Hepatitis C Viral Clearance on the CD4 (+) T Cell Lymphocyte Course in HIV/HCV Coinfected Patients by J. Dazley, R. Sison, J. Slim

    Published 2015-01-01
    “…The long-term impact of pegylated-interferon plus ribavirin treatment outcome on CD4 T cell course in patients coinfected with human immunodeficiency virus and hepatitis C virus is largely unclear in the literature. …”
    Get full text
    Article
  18. 258

    A two-strain HIV-1 mathematical model to assess the effects of chemotherapy on disease parameters by Tinevimbo Shiri, Winston Garira, Senelani D. Musekwa

    Published 2005-09-01
    “…Treatment of human immunodeficiency virus type 1 (HIV-1) infection during the symptomatic phase has significantly improved patient survival. …”
    Get full text
    Article
  19. 259

    Pondering Parotid Masses by Mark A Miller

    Published 2001-01-01
    “…A49-year-old, human immunodeficiency virus (HIV)- infected, Haitian-born woman presented with a left facial mass that she had noticed for the previous eight weeks. …”
    Get full text
    Article
  20. 260

    A Study of Sociodemographic Determinants of Consistent and Correct Condom Use among Homosexual Males Aged 18–24 Years in a Metropolitan City by Yashowardhan V. Totala, Abhiram M. Kasbe, Rupali R. Rajput

    Published 2025-01-01
    “…Background: One of the biggest problems faced by the homosexual population is the high prevalence of sexually transmitted diseases including human immunodeficiency virus which can be attributed to inconsistent and incorrect use of condom. …”
    Get full text
    Article